Back
Day Range
$12.13
$12.77
52-Week Range
$8.81
$23.29
Volume
1,908,974
50D / 200D Avg
$14.45
/
$15.45
Prev Close
$12.37
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -12.8 | 0.4 |
| P/B | 51.0 | 2.9 |
| ROE % | -630.7 | 3.7 |
| Net Margin % | -18.8 | 3.8 |
| Rev Growth 5Y % | 33.1 | 10.0 |
| D/E | 17.2 | 0.2 |
Key Takeaways
Revenue grew 33.14% annually over 5 years — strong growth
Debt/Equity of 17.21 — high leverage
Generating 2.78M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 8.19%
Capital efficient — spends only 5.56% of revenue on capex
Growth
Revenue Growth (5Y)
33.14%
Revenue (1Y)24.95%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-630.66%
ROIC-9.39%
Net Margin-18.76%
Op. Margin-10.75%
Safety
Debt / Equity
17.21
Current Ratio2.06
Interest Coverage-3.88
Valuation
P/E Ratio
-12.83
P/B Ratio51.04
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 24.95% | Revenue Growth (3Y) | 25.88% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 33.14% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 764.16M | Net Income (TTM) | -143.36M |
| ROE | -630.66% | ROA | -18.12% |
| Gross Margin | 69.60% | Operating Margin | -10.75% |
| Net Margin | -18.76% | Free Cash Flow (TTM) | 2.78M |
| ROIC | -9.39% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 17.21 | Current Ratio | 2.06 |
| Interest Coverage | -3.88 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -12.83 | P/B Ratio | 51.04 |
| P/S Ratio | 2.41 | PEG Ratio | 1.46 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.84B | Enterprise Value | 2.30B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 764.16M | 611.56M | 482.26M | 350.87M | 243.21M |
| Net Income | -143.36M | -162.12M | -186.64M | -151.29M | -143.03M |
| EPS (Diluted) | -0.96 | -1.13 | -1.54 | -1.47 | -1.50 |
| Gross Profit | 531.89M | 424.26M | 310.20M | 233.06M | 157.76M |
| Operating Income | -82.13M | -136.17M | -173.40M | -146.98M | -128.06M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 791.21M | 775.71M | 805.21M | 520.97M | 572.05M |
| Total Liabilities | 755.18M | 766.28M | 703.49M | 555.64M | 492.63M |
| Shareholders' Equity | 36.03M | 9.43M | 101.72M | -34.67M | 79.42M |
| Total Debt | 619.95M | 609.94M | 541.68M | 395.86M | 355.43M |
| Cash & Equivalents | 160.81M | 138.84M | 220.97M | 84.70M | 187.25M |
| Current Assets | 450.88M | 417.40M | 451.09M | 255.63M | 331.16M |
| Current Liabilities | 219.18M | 153.03M | 157.57M | 138.87M | 101.10M |